Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension

American Journal of Cardiology

Volumn 84, Issue 4, 1999, Pages 481-484

  Hinderliter, Alan L ^a   Willis IV, Park W ^a   Long, Walker ^a   Clarke, William R ^b   Ralph, David ^b   Caldwell, Edgar J ^c   Williams, William ^c   Ettinger, Neil A ^d   Hill, Nicholas S ^e   Summer, Warren R ^f   De Boisblanc, Bennett ^f   Koch, Gary ^g   Li, Shu ^g   Clayton, Linda M ^h   Jöbsis, Maria M ^h   Crow, James W ⁱ  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c MAINE MEDICAL CENTER   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e Rhode Island Hospitals ^*  (United States)

^f Maxillofacial Prosthetics Service   (United States)

^g IL   (United States)

^h GLAXOSMITHKLINE   (United States)

ⁱ UNITED THERAPEUTICS CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC GLYCOSIDE; DIURETIC AGENT; PROSTACYCLIN; VASODILATOR AGENT; WARFARIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXERCISE TOLERANCE; FEMALE; HEART RIGHT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; OXYGEN THERAPY; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

ADULT; ANTIHYPERTENSIVE AGENTS; ECHOCARDIOGRAPHY, DOPPLER; EPOPROSTENOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; INFUSIONS, INTRAVENOUS; MALE; PERICARDIAL EFFUSION; PREVALENCE; PROGNOSIS; PULMONARY WEDGE PRESSURE; SURVIVAL RATE;

EID: 0033566838     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00342-2     Document Type: Article

References (11)

1. Eysmann S.B., Palevsky H.I., Reichek N., Hackney K., Douglas P.S. Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in PPH. Circulation. 80:1989;353-360.
2. Louie E.K., Rich S., Levitsky S., Brundage B.H. Doppler echocardiographic assessment of impaired left ventricular filling in patients with right ventricular pressure overload due to PPH. J Am Coll Cardiol. 8:1986;1298-1306.
3. Rich S., Brundage B.H. High-dose calcium channel-blocking therapy for PPH evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy . Circulation. 76:1987;135-141.
4. Goodman D.J., Harrison D.C., Popp R.L. Echocardiographic features of PPH. Am J Cardiol. 33:1974;438-443.
5. Hinderliter A.L., Willis P.W. IV, Barst R.J., Rich S., Rubin L.J., Badesch D.B., Groves B.M., McGoon M.D., Tapson V.F., Bourge R.C., Brundage B.H., Koerner S.K., Langleben D., Keller C.A., Murali S., Uretsky B.F., Koch G., Li S., Clayton L.M., Jöbsis M.M., Blackburn S.D. Jr, Crow J.W., Long W.A. Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Circulation. 95:1997;1479-1486.
6. Barst R.J., Rubin L.J., Long W.A., McGoon M.D., Rich S., Badesch D.B., Groves B.M., Tapson V.F., Bourge R.C., Brundage B.H., Loerner S.K., Langleben D., Keller C.A., Murali S., Uretsky B.F., Clayton L.M., Jöbsis M.M., Blackburn S.D., Shortino D., Crow J.W. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 334:1996;296-301.
7. Rich S., Dantzker D.R., Ayres S.M., Ayres S.M., Bergofsky E.H., Brundage B.H., Detre K.M., Fishman A.P., Goldring R.M., Groves B.M., Loerner S.K., Levy P.C., Reid L.M., Vreim C.E., Williams G.W. PPH a national prospective study . Ann Intern Med. 107:1987;216-223.
8. Ryan T., Petrovic O., Dillon J.C., Feigenbaum H., Conley M.J., Armstrong W.F. An echocardiographic index for separation of right ventricular volume and pressure overload. J Am Coll Cardiol. 5:1985;918-924.
9. Guyatt G.H., Sullivan M.J., Thompson P.J., Fallen E.L., Pugsley S.O., Taylor D.W., Berman L.B. The 6-minute walk a new measure of exercise capacity in patients with chronic heart failure . Can Med Assoc J. 132:1985;919-923.
10. Fuster V., Steele P.M., Edwards W.D., Gersh B.J., McGoon M.D., Frye R.L. PPH natural history and the importance of thrombosis . Circulation. 70:1984;580-587.
11. D'Alonzo G.E., Barst R.J., Ayres S.M., Bergofsky E.H., Brundage B.H., Detre K.M., Fishman A.P., Goldring R.M., Groves B.M., Kernis J.T., Levy P.S., Pietra G.G., Reid L.M., Reeves J.T., Rish S., Vreim C.E., William G.W., Wu M. Survival in patients with PPH results from a national prospective registry . Ann Intern Med. 115:1991;343-349.